Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

UK – GSK’s Blenrep combination recommended by NICE to treat multiple myeloma

GSK’s Blenrep (belantamab mafodotin) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a combination treatment for multiple myeloma (MM).

The health technology assessment agency has recommended in draft guidance that the antibody-drug conjugate be used on the NHS alongside bortezomib plus dexamethasone (BVd) as a second-line MM treatment for adults who are refractory to, or intolerant of, lenalidomide.

The decision means that eligible patients will be the first in the world to access the combination.

More information on PMLiVE.


OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (28 juillet 2025). UK – GSK’s Blenrep combination recommended by NICE to treat multiple myeloma. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/14fyr


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.